<DOC>
	<DOCNO>NCT00646321</DOCNO>
	<brief_summary>The purpose study compare Symbicort budesonide alone treatment asthma child age 6 15 year</brief_summary>
	<brief_title>Efficacy Symbicort pMDI Administered Once Daily Children Adolescents During 12 Weeks - SPROUT</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>At least 6 maximally 15 year age Diagnosis asthma baseline lung function test determine protocol Has require receive treatment inhaled corticosteroid within timeframe dos specify protocol Severe asthma Has require treatment noninhaled corticosteroid within previous 4 week , sensitivity drug specify protocol require treatment betablockers</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>asthma</keyword>
	<keyword>child</keyword>
	<keyword>adolescent</keyword>
	<keyword>Symbicort</keyword>
	<keyword>budesonide/ formoterol</keyword>
	<keyword>budesonide</keyword>
</DOC>